RESUMEN
This study was retrospective, conducted over seven years at the Trauma and Burn Centre. Its purpose was to establish the bacteriological profile and antibiotic resistance of isolated bacteria in patients admitted to the Burn Intensive Care Unit. Identification was carried out according to the conventional methods and antibiotic susceptibility was analyzed according to the standards of the Antibiogram Committee of the French Society of Microbiology. Pseudomonas aeruginosa was the main isolated bacterium, followed by Staphylococcus aureus, Klebsiella pneumoniae and Acinetobacter baumannii. These strains were isolated mainly from haemocultures (37%). The resistance of Pseudomonas aeruginosa to ceftazidime increased from 9.2% in 2012 to 53.5% in 2018. The resistance to imipenem and ciprofloxacin was 63.3% and 42.9%, respectively. Four strains were resistant to colistin. The resistance of S. aureus to meticillin decreased from 65.3% in 2012 to 41.6% in 2018. All strains were susceptible to glycopeptides, tigecycline and linezolid. A. baumannii was multi-resistant to antibiotics with 81.8% resistance to ceftazidime, 88.9% to amikacin, 90.5% to ciprofloxacin and 94.5% to imipenem. Sixteen strains were resistant to colistin. Concerning K. pneumoniae, 77.5% of strains were resistant to cefotaxime and 5.2% to imipenem. Two strains were resistant to colistin. Vancomycin resistance in Enterococcus faecium increased from 33.4% in 2012 to 72.2% in 2018. Multidrug resistance in burn patients calls for an epidemiological surveillance of bacterial ecology and the application of hygiene measures.